about
High-mobility group box-1 protein, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in children with community acquired infections and bacteraemia: a prospective study.The antimicrobial peptide lysozyme is induced after multiple traumaProcalcitonin as a potent marker of bacterial infection in febrile Afro-Caribbean patients at the emergency department.Evaluation of procalcitonin, C-reactive protein, interleukin-6 & serum amyloid A as diagnostic biomarkers of bacterial infection in febrile patients.Evaluation of the Light-Cycler® SeptiFast Test in Newborns With Suspicion of Nosocomial Sepsis.Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infeMicrofilariae of the filarial nematode Litomosoides sigmodontis exacerbate the course of lipopolysaccharide-induced sepsis in micePrognostic utility and characterization of cell-free DNA in patients with severe sepsisUseulness of B Natriuretic Peptides and Procalcitonin in Emergency Medicine.Neutrophil CD64: a diagnostic marker for infection and sepsis.Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia.Role of suPAR and Lactic Acid in Diagnosing Sepsis and Predicting Mortality in Elderly PatientsProcalcitonin: a key marker in children with urinary tract infection.Restoration of antioxidant enzymes in the therapeutic use of selenium in septic patients.Interleukin-18, CRP and procalcitonin levels in vesicoureteral reflux and reflux nephropathy.Procalcitonin as a Marker for the Detection of Bacteremia and Sepsis in the Emergency Department
P2860
Q33531533-94C84CF3-37E9-4F99-A37A-EE58EC69A21EQ34204614-79E2B718-B260-454D-BB2C-6407BEB02604Q35013834-28037E08-645F-4BF4-A1D1-E753AB6DB9B3Q35640871-85D1B43D-1ED8-47C9-9D87-445A29B27AFEQ35862022-EA7B2169-7F41-4F0A-A555-BB66D886C2BCQ36392555-9866A11D-CD4A-433F-9FEA-43CA582A0594Q36539614-F0AE8C8C-3F92-42E3-9457-E212AD23C145Q36634005-EF10B666-C072-4D6F-BD36-208187D64595Q37207285-28525862-E499-494C-95AA-323BC8C8D1F7Q37566603-1AB8A16D-1BE8-4DA1-BE34-4C25D883856CQ40413348-3FE983DB-CAD5-40FC-8717-E9F6490B1B90Q41453402-FD2BFCBF-8FFD-4C9A-8148-D914E290AEFFQ42580295-ABFBA93E-635E-4B2A-BBC6-383BF91F93A3Q44927083-1383E1DB-93C3-470B-9764-014F077EEB65Q47749123-9C60D2EE-8616-4E69-ACA9-2AC585557159Q56428429-6EDBA07F-48B2-40CA-BACC-DBB7CD1802DA
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Biomarkers of sepsis: clinically useful?
@ast
Biomarkers of sepsis: clinically useful?
@en
type
label
Biomarkers of sepsis: clinically useful?
@ast
Biomarkers of sepsis: clinically useful?
@en
prefLabel
Biomarkers of sepsis: clinically useful?
@ast
Biomarkers of sepsis: clinically useful?
@en
P1476
Biomarkers of sepsis: clinically useful?
@en
P2093
Michael Meisner
P304
P356
10.1097/01.CCX.0000176694.92883.CE
P577
2005-10-01T00:00:00Z